Systematic review: Men with COVID-19 have almost three times the risk of requiring ICU admission and a higher risk of death
Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission – Nature Medicine Commentary: Men face ‘almost three times the odds’ of ICU admission for Covid-19, study says – CNN AND Men with COVID-19 three times more likely to need intensive care: study – MedicalXpress Commentary on Twitter […]
The post Systematic review: Men with COVID-19 have almost three times the risk of requiring ICU admission and a higher risk of death appeared first on Links Medicus.
Another randomized trial shows hydroxychloroquine is not effective as postexposure prophylaxis to prevent Covid-19
Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Randomized Trial – Annals of Internal Medicine Summary for patients: Summary for Patients: Postexposure Hydroxychloroquine Prophylaxis to Prevent SARS-CoV-2 Infection
The post Another randomized trial shows hydroxychloroquine is not effective as postexposure prophylaxis to prevent Covid-19 appeared first on Links Medicus.
CDC releases new ventilation guidelines for indoor environments to reduce Covid-19 risk
CDC Releases New Ventilation Guidelines For Indoor Environments To Reduce Covid-19 Risk – Forbes CDC Guideline: Ventilation Related podcast: Air Handling Standards for Increasing the Safety of Indoor Spaces During the COVID-19 Pandemic – JAMA
The post CDC releases new ventilation guidelines for indoor environments to reduce Covid-19 risk appeared first on Links Medicus.
Just published: AstraZeneca-Oxford Covid-19 vaccine shows moderate efficacy, but questions remain about the most effective dosing regimen
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK – The Lancet Commentaries: Oxford COVID vaccine paper highlights lingering unknowns about results – Nature AND Detailed data on AstraZeneca-Oxford Covid-19 vaccine show it has moderate efficacy – STAT […]
The post Just published: AstraZeneca-Oxford Covid-19 vaccine shows moderate efficacy, but questions remain about the most effective dosing regimen appeared first on Links Medicus.
Opinion: “Get ready for vaccine false side effects”. When millions of people are vaccinated, naturally occurring health problems could be wrongly attributed to vaccines
Get Ready for False Side Effects – Science Translational Medicine
The post Opinion: “Get ready for vaccine false side effects”. When millions of people are vaccinated, naturally occurring health problems could be wrongly attributed to vaccines appeared first on Links Medicus.
If exposed to Covid-19, how long before you have symptoms? Median incubation is 5.1 days, and 97.5% of those who develop symptoms do so within 11.5 days of being exposed to the virus
If Exposed To Covid-19 Coronavirus, How Long Before You Have Symptoms – Forbes
The post If exposed to Covid-19, how long before you have symptoms? Median incubation is 5.1 days, and 97.5% of those who develop symptoms do so within 11.5 days of being exposed to the virus appeared first on Links Medicus.
First-of-its-kind African trial tests common drugs to prevent severe COVID-19. “Could cheap, widely available drugs prevent patients with mild illness from becoming severely sick?”
First-of-its-kind African trial tests common drugs to prevent severe COVID-19 – Science
The post First-of-its-kind African trial tests common drugs to prevent severe COVID-19. “Could cheap, widely available drugs prevent patients with mild illness from becoming severely sick?” appeared first on Links Medicus.
Randomized trial: High-dose influenza vaccine shows no additional benefit for heart disease patients
Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial – JAMA Editorial: Influenza Vaccine for Patients With High-risk Cardiovascular Disease Commentary: High-dose influenza vaccine shows no additional benefit for heart disease patients – NIH News Releases Commentary on Twitter […]
The post Randomized trial: High-dose influenza vaccine shows no additional benefit for heart disease patients appeared first on Links Medicus.
Study in Germany comparing regions with vs. without mask mandates concluded that 20 d after becoming mandatory, face masks reduced new Covid-19 infections by around 45%
Face masks considerably reduce COVID-19 cases in Germany – Proceedings of the National Academy of Sciences
The post Study in Germany comparing regions with vs. without mask mandates concluded that 20 d after becoming mandatory, face masks reduced new Covid-19 infections by around 45% appeared first on Links Medicus.
The UK has approved a COVID vaccine — but scientists still have many questions. One of them is if the vaccines will prevent the transmission of the disease
The UK has approved a COVID vaccine — here’s what scientists now want to know – Nature
The post The UK has approved a COVID vaccine — but scientists still have many questions. One of them is if the vaccines will prevent the transmission of the disease appeared first on Links Medicus.